CN1688543A - 呋喃酮衍生物及其制备方法 - Google Patents

呋喃酮衍生物及其制备方法 Download PDF

Info

Publication number
CN1688543A
CN1688543A CNA038243997A CN03824399A CN1688543A CN 1688543 A CN1688543 A CN 1688543A CN A038243997 A CNA038243997 A CN A038243997A CN 03824399 A CN03824399 A CN 03824399A CN 1688543 A CN1688543 A CN 1688543A
Authority
CN
China
Prior art keywords
replacement
unsubstituted
compound
halogen
arylalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA038243997A
Other languages
English (en)
Chinese (zh)
Inventor
纳雷什·库马尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biosignal Australia Pty Ltd
Original Assignee
Biosignal Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosignal Australia Pty Ltd filed Critical Biosignal Australia Pty Ltd
Publication of CN1688543A publication Critical patent/CN1688543A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/06—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
    • A01N43/08—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings with oxygen as the ring hetero atom
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/36—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/60—Two oxygen atoms, e.g. succinic anhydride
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/66—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Pyrrole Compounds (AREA)
  • Cultivation Of Plants (AREA)
  • Furan Compounds (AREA)
  • Medicinal Preparation (AREA)
CNA038243997A 2002-08-19 2003-08-19 呋喃酮衍生物及其制备方法 Pending CN1688543A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2002950862 2002-08-19
AU2002950862A AU2002950862A0 (en) 2002-08-19 2002-08-19 Furanone derivatives and methods of making same

Publications (1)

Publication Number Publication Date
CN1688543A true CN1688543A (zh) 2005-10-26

Family

ID=27809947

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA038243997A Pending CN1688543A (zh) 2002-08-19 2003-08-19 呋喃酮衍生物及其制备方法

Country Status (7)

Country Link
US (1) US20050215772A1 (https=)
EP (1) EP1539692A4 (https=)
JP (1) JP2006514610A (https=)
CN (1) CN1688543A (https=)
AU (1) AU2002950862A0 (https=)
CA (1) CA2495784A1 (https=)
WO (1) WO2004016588A1 (https=)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101503397B (zh) * 2009-03-23 2012-07-18 暨南大学 卤代呋喃酮化合物及其在制备抗感染药物上的应用
CN105050393A (zh) * 2013-02-01 2015-11-11 荷兰联合利华有限公司 包含内酰胺和助水溶剂的抗微生物组合物
CN107920979A (zh) * 2015-08-20 2018-04-17 荷兰联合利华有限公司 改善的内酰胺溶解度
CN108024938A (zh) * 2015-08-20 2018-05-11 荷兰联合利华有限公司 改善的内酰胺溶解度
CN106518818B (zh) * 2016-10-14 2018-07-27 宁波大学 一种呋喃酮类化合物及其制备方法和用途
CN109705068A (zh) * 2019-02-27 2019-05-03 重庆医药高等专科学校 原白头翁素合成方法
CN109922659A (zh) * 2016-11-17 2019-06-21 荷兰联合利华有限公司 内酰胺组合物
US10918107B2 (en) 2015-05-20 2021-02-16 Conopco, Inc. Encapsulated lactams
US10986837B2 (en) 2015-08-20 2021-04-27 Conopco, Inc. Lactam solubility
US11077036B2 (en) 2015-08-20 2021-08-03 Conopco, Inc. Lactam solubility

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1909900A (zh) * 2003-12-05 2007-02-07 拜欧希格诺有限公司 抗微生物化合物与表面和聚合物的缔合
JP5133067B2 (ja) * 2005-02-04 2013-01-30 ウイスコンシン アラムナイ リサーチ ファウンデーシヨン クオラムセンシング細菌におけるコミュニケーション及び毒性を変更するための化合物及び方法
JP4969065B2 (ja) * 2005-07-13 2012-07-04 株式会社 メドレックス 常温性イオン性液体を含有する医薬組成物
JP2009523834A (ja) 2006-01-24 2009-06-25 バイオシグナル リミテッド 新規ラクタム
AU2015200142B2 (en) * 2006-01-24 2016-07-07 Unilever Plc Novel lactams
WO2007133777A1 (en) * 2006-05-15 2007-11-22 Tyco Healthcare Group Lp Furanone endcapped polymers
EP2026825A4 (en) * 2006-05-15 2012-07-04 Tyco Healthcare FURANON-INITIATED POLYMERS
AU2007304839A1 (en) * 2006-10-06 2008-04-10 Unilever Plc Furanone compounds and lactam analogues thereof
JP5762683B2 (ja) 2006-12-01 2015-08-12 ラクレード，インコーポレーテッド 耳内のバイオフィルムを溶解するための加水分解酵素及び酸化酵素の使用
EP2136800A4 (en) * 2007-03-19 2011-10-05 Wisconsin Alumni Res Found MODULATION OF BACTERIAL QUORUM DETECTION WITH SYNTHETIC LIGANDS
US8624063B2 (en) 2009-06-30 2014-01-07 Wisconsin Alumni Research Foundation Non-lactone carbocyclic and heterocyclic antagonists and agonists of bacterial quorum sensing
EP2425862B1 (de) * 2010-09-07 2012-08-29 Miele & Cie. KG Verfahren zur Reinigung und thermischen Desinfektion von Spülgut
CN102002024B (zh) * 2010-11-19 2012-10-10 吉首大学 3-芳基-4-芳氨基-2（5h）-呋喃酮型化合物及其制法和用途
ES2660822T3 (es) * 2012-09-21 2018-03-26 Rhode Island Hospital Inhibidores de beta-hidrolasa para tratamiento del cáncer
WO2014183164A1 (en) * 2013-05-17 2014-11-20 Naresh Kumar Dihydropyrrolones and their use as antimicrobial agents
WO2016176146A1 (en) * 2015-04-26 2016-11-03 The Trustees Of Princeton University Surfaces comprising attached quorum sensing modulators
CN107920977A (zh) * 2015-08-20 2018-04-17 荷兰联合利华有限公司 内酰胺组合物
US11083706B2 (en) 2016-07-21 2021-08-10 Conopco, Inc. Lactams for use in the treatment of skin lesions
US10875830B2 (en) 2016-07-21 2020-12-29 Conopeo, Inc. Method of treatment
US11160787B2 (en) 2016-07-21 2021-11-02 Conopco, Inc. 4-(4-chlorophenyl)-5-methylene-pyrrol-2-one and 5-methylene-4-(p-tolyl)pyrrol-2-one for use in the treatment of gram negative bacterial infections
CN109862788A (zh) 2016-11-17 2019-06-07 荷兰联合利华有限公司 内酰胺组合物
US10526278B2 (en) 2017-10-19 2020-01-07 Wisconsin Alumni Research Foundation Inhibitors of quorum sensing receptor LasR
RU2691634C2 (ru) * 2017-11-27 2019-06-17 Федеральное Государственное бюджетное научное учреждение Всероссийский научно-исследовательский институт мясного скотоводства СПОСОБ ПРИМЕНЕНИЯ ГАММА-ОКТАЛАКТОНА В КАЧЕСТВЕ ИНГИБИТОРА СИСТЕМЫ "КВОРУМ СЕНСИНГА" LuxI/LuxR ТИПА У БАКТЕРИЙ
US20230148597A1 (en) * 2020-04-21 2023-05-18 Conopco, Inc., D/B/A Unilever Varnish
US12410319B2 (en) * 2020-06-23 2025-09-09 Akzo Nobel Coatings International B.V. Radiation-curable coating composition, method of coating a substrate and coated substrate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755356A (en) * 1969-11-06 1973-08-28 Zoecon Corp Substituted crotonic amide ypsilon-lactams
AUPM666694A0 (en) * 1994-07-06 1994-07-28 Unisearch Limited Natural antifouling compositions
AUPQ841900A0 (en) * 2000-06-28 2000-07-20 Unisearch Limited Synthesis of cyclic compounds

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101503397B (zh) * 2009-03-23 2012-07-18 暨南大学 卤代呋喃酮化合物及其在制备抗感染药物上的应用
CN105050393B (zh) * 2013-02-01 2018-07-03 荷兰联合利华有限公司 包含内酰胺和助水溶剂的抗微生物组合物
CN105050393A (zh) * 2013-02-01 2015-11-11 荷兰联合利华有限公司 包含内酰胺和助水溶剂的抗微生物组合物
US9930888B2 (en) 2013-02-01 2018-04-03 Conopco, Inc. Composition
US10918107B2 (en) 2015-05-20 2021-02-16 Conopco, Inc. Encapsulated lactams
US10888087B2 (en) 2015-08-20 2021-01-12 Conopco, Inc. Lactam solubility
CN108024938A (zh) * 2015-08-20 2018-05-11 荷兰联合利华有限公司 改善的内酰胺溶解度
CN107920979A (zh) * 2015-08-20 2018-04-17 荷兰联合利华有限公司 改善的内酰胺溶解度
US10986837B2 (en) 2015-08-20 2021-04-27 Conopco, Inc. Lactam solubility
US11077036B2 (en) 2015-08-20 2021-08-03 Conopco, Inc. Lactam solubility
CN116983220A (zh) * 2015-08-20 2023-11-03 联合利华知识产权控股有限公司 改善的内酰胺溶解度
CN106518818B (zh) * 2016-10-14 2018-07-27 宁波大学 一种呋喃酮类化合物及其制备方法和用途
CN109922659A (zh) * 2016-11-17 2019-06-21 荷兰联合利华有限公司 内酰胺组合物
CN109705068A (zh) * 2019-02-27 2019-05-03 重庆医药高等专科学校 原白头翁素合成方法

Also Published As

Publication number Publication date
US20050215772A1 (en) 2005-09-29
JP2006514610A (ja) 2006-05-11
EP1539692A4 (en) 2005-08-24
CA2495784A1 (en) 2004-02-26
WO2004016588A1 (en) 2004-02-26
EP1539692A1 (en) 2005-06-15
AU2002950862A0 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
CN1688543A (zh) 呋喃酮衍生物及其制备方法
US9586901B2 (en) Lactams
US8586618B2 (en) Furanone compounds and lactam analogues thereof
US8653124B2 (en) Inhibition of bacterial biofilms with imidazole derivatives
CN1044234C (zh) 取代的苯基咪唑烷类、其制法、用途及含有它们的药物组合物
CN1423632A (zh) 芳族二酰胺衍生物或其盐、农艺组合物及其使用方法
NO991700L (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
WO2005058790A1 (ja) リゾホスファチジン酸受容体拮抗作用を有する化合物およびその用途
CN1358173A (zh) 杂环二羧酸二酰胺衍生物,农业和园艺杀虫剂以及使用它们的方法
CN1319086A (zh) 邻氨基苯甲酸衍生物
CN1839204A (zh) 自诱导剂类似物的组合库,自诱导剂激动剂和拮抗剂,以及它们的使用方法
CN1909900A (zh) 抗微生物化合物与表面和聚合物的缔合
CN1215052C (zh) 异羟肟酸的磺酸衍生物及其医药用途
CN1511034A (zh) 用于治疗与过度细胞因子活性相关的疾病的异噁唑酮化合物
CN1603307A (zh) 氰基丙烯酸酯衍生物及制备方法和生物活性
AU2015200142B2 (en) Novel lactams
CN101039963A (zh) 生物素化十六糖，它们的制备方法及其用途
AU2003257229A1 (en) Furanone derivatives and methods of making same
WO2007029078A2 (en) Succinimide and glutarimide derivatives as adrenergic receptor antagonists
HK1096125A (en) Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
CN1871247A (zh) 新型次磺酰胺
CN1871248A (zh) 新型次磺酰胺氧化物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20051026